In human genetic studies, it was found that serotonin mediation in CNS is responsible for the development of metabolic syndrome, insulin resistance, and type 2 diabetes, as it is associated with polymorphism in SERT genes [36]. The gene discussed is SLC6A4; the disease is metabolic syndrome.